George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Greed is not new to AIM. The BoD will do what ever they please, simply because they can. The current SP may not be of too much immediate concern to them, as they really do not wish to raise fresh cash, and they can stick it out, as this is their day job....for life.
Judging by the size of sells and number of trades, my guess is that they are frustrated bunch of groupies FUM picked up following recommendations and launch time. The SP drop certainly does not reflect the size of activity.
During the interim results presentation COO Angela Hildreth stated the will be at least 10 new country launches in the next 6 months. By my reckoning we’re due some good news very soon!
Also noticed on the product innovation slide, a pump action dispenser - that’s something to get excited about. The Futura is getting brighter!
My take ? Rns
Options granted not at 20p or 2p!
At NIL ...ZILCH cost!!
25% can be converted now if want. Rest over 3 yrs at certain points and still an employee.
Your analysis PetitStVincent is nicely thought through and helpful. Thank you for that.
I'm not sure as to what 0.02p actually means in the context of today's Options announcement but I don't think it means 20p - isn't it a fraction of 1p or at maximum 2p ?
The point is the options are simply 'capitalist greed at the extreme' as the Directors/Senior management are paid well (in fact they've secured increases if the reports are examined) and here we have yet more options - some of which are immediately exercisable at a bountiful rate. Compare this with the last share placing that I subscribed for in 2021 of 40p per share. What about the Shareholders Mr Barder who have paid their way to your success ?
The Chinese angle , particularly Co-High needs some explanatory update given that is over 2 years that agreement was signed and we need to be told what is the holdup there - especially as it was felt the US FDA approval was a protracted exercise and yet has now been completed - so what is happening in China - solve that successfully (by which I mean profitably) Mr Barder and you could be thought worthy of yet more options.
In the meantime, I think today's announcement stinks !
Another 25% x 10.6m = 2.65m shares that can now possibly be sold into a market which indigestion for Futura’s shares, forcing the price to reverse from 65p in July to less than 40p tonight. Not good, especially when the big seller for months (I suspect Co High) may not be finished yet. The supply-demand imbalance needs to be reversed, not exacerbated through a possible additional 2.65m shares looking for a new home.
I understand the two events - grant of options and share price fall - are independent. But the optics of granting the options at 20p against this backdrop is slightly bizarre. They will simply reward keeping existing office seats warm rather than behaviours that drive the share price higher.
If there were eager new investors looking to buy Futura’s shares, I’m sure none of us would really care. Apart from licensing in China, Futura’s Executive has pretty much delivered on things within its control. But the shares are currently friendless, with their price the best part of £1 below where its own analysts believe it should be.
“Signalling” is a hugely important factor in business. For example, in insurance, we may opt for a higher voluntary excess, signalling that we are less likely to make a claim, which reduces our premium.
Today, Futura could have sent a signal to the market of its confidence in the future level of its share price by pitching the vesting price for the majority of options much higher - say, 80p, or even £1. It bottled the opportunity, taking the lowest road possible, by granting options with an immediate 100% upside.
That’s not aligning shareholders’ interests (higher price) with employees’ interest, which - whilst also is a higher price - is “already in the money”, so they can still turn around happy at any share price above 20p between now and October 2026. Many shareholders need far higher exit prices to see a profit.
The mood music surrounding Futura has soured since the Haleon deal in general, but the interims in particular. That may simply be (and I feel overwhelmingly is) the Co High “exit effect” (millions of shares being sold after termination of its agreement with Futura).
Currently, we shareholders are not happy bunnies. At all. Now more than ever, James and his team should consider much more carefully the optics of their words and actions on investor sentiment.
it's about time the management (who i don't really like and have said many times) should actually put their money in their pockets and buy some, to show confidence, especially with the state of the share price at the moment.
but why would they when they keep getting **** loads free for not doing much. i've been around for a while, so seeing the share price at this level with all that has happened recently is making management look incompetent.
in the past when the share price has spiked up they come out with an rns saying they have no idea of the price increase, but nothing with the constant drip....
thankfully i don't need access to my share but i feel sorry for the holders that bought at the top
Yes ,the lock in period is a positive.in the event of a T/O before the exercise cut off there will doubtless be provisions to compensate etc. i really don't see anything unreasonable or untoward here at all.
Well deserved I'd say.
Big bonus is stability of having the directors locked in for 3 years 👍
Fumble Medical, BoD dropping the ball again in their greedy rush to the trough. I sincerely believe that our only hope of a decent price rise is to be swallowed, and quick.
Personally i don't have problem with the awards, as i think it aligns the directors' interests more closely with those of the company. my only qualification would be that the exercise price is pretty low, so slightly disappointed in that.
Greed is not a good look ,will not do a lot for the current sp,
Nearly 5% of the company, how nice for them also noticed director wage bill was £1.2mill versus £500k 3 years ago and only one extra director.
What's wrong with the colour of the SP?
It's a strange blue colour!?!
One thing that FUM have got right is manufacturing it themselves, this means that if they have any issues with licensee’s they can take back the license and re-issue license to someone else.
I hadn’t realised FUM had any products before CDS500-condom, so now having read all about PET500-spray to stop premature ejack that worked & had a US roll-out! But failed to sell I’m not surprised there is some hesitation with the share price! But FUM are not new to this either & have no excuse for poor RNS’s as have had plenty of experience IMO! Not sure if this settles my nerves but does explain alot, and until we see real re-occurring profit I think it’s a waiting game. Was anyone invested around the time of PET500?
Morning dosanddonts. fair point. let us hope they have learned from previous experiences.
Italian-let’s hope so, I realise FUM have also been shafted in the past by commercial partners, which is why I hope they are in total control this time round. GSK we’re the shafter on at least one occasion!
Share price has erectile dysfunction
It's true that they have got other products to market before, but i donot think any of them have had the partnerships and distribution backing which this has . imo it is of a completely different order.
I think it is the state of the market , little to no new money coming in which leaves the flippers in control ie. the inmates are currently running the asylum .
FUM has manage to get multiple products to market but products have failed to gain traction! PET500 & CSD500 both failed in sales so to me this is what’s holding SP back! sales, sales, sales=profit
How much longer can this be drifting down?
Lol na, 20 quid think long term sir!
GSK can have mine for £10.00.
...GSK are raising cash to buy FUM.
Just sold £885m worth of Haleon, should just about cover it!